Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
J Nutr ; 129(10): 1820-6, 1999 Oct.
Article in English | MEDLINE | ID: mdl-10498753

ABSTRACT

Isoflavones in soy may play a role in the prevention of cancer through their capacity to affect antioxidant or protective phase II enzyme activities. This study evaluated the effects of dietary isoflavone levels on the induction of antioxidant and phase II enzyme activities and inhibition of breast carcinogenesis. Female Sprague-Dawley rats (36 d) were fed one of four purified diets with casein, or with soy containing three levels of isoflavonoids (0.03, 0.4 or 0.81 mg/g diet; low, middle and high level of isoflavones, respectively). After 2 wk, enzyme activity was determined of rats (n = 6-7) from each diet group. Liver glutathione peroxidase and glutathione reductase activities, blood glutathione levels, kidney glutathione S-transferase and colon quinone reductase (QR) activities were greater in rats consuming the high isoflavone diet compared to rats consuming the casein diet. Kidney QR and liver, kidney, small intestine, and colon UDP-glucuronosyltransferase activities were greater in rats fed the high isoflavone diet compared to rats fed the casein and low-isoflavone diets. Liver and blood oxidized glutathione were lower in rats fed the high-isoflavone diet compared to those fed the low-isoflavone diet. A subset of rats (n = 86) was fed the purified diets for 2 wk and intubated with dimethylbenz[a]anthracene or peanut oil and palpated weekly for tumors. At 13 wk, there was an inverse relationship (R(2) = 0.911, P < 0.09) between tumor incidence and increasing isoflavone intake. These data support the mechanism of soy and soy isoflavones as antioxidant and phase II enzyme inducers, but not as tumor inhibitors.


Subject(s)
9,10-Dimethyl-1,2-benzanthracene/antagonists & inhibitors , Glutathione/metabolism , Isoflavones/pharmacology , Liver/enzymology , Mammary Neoplasms, Animal/prevention & control , Neoplasms, Experimental/prevention & control , Soybean Proteins/pharmacology , Animals , Antioxidants/metabolism , Caseins/administration & dosage , Caseins/pharmacology , Diet , Dose-Response Relationship, Drug , Enzyme Induction/drug effects , Female , Glutathione/blood , Glutathione Peroxidase/metabolism , Glutathione Reductase/metabolism , Isoflavones/therapeutic use , Liver/drug effects , Mammary Neoplasms, Animal/chemically induced , Neoplasms, Experimental/chemically induced , Rats , Rats, Sprague-Dawley , Soybean Proteins/administration & dosage , Transferases/metabolism
2.
Nutr Cancer ; 28(3): 270-5, 1997.
Article in English | MEDLINE | ID: mdl-9343836

ABSTRACT

The ability of soy to induce phase II detoxification enzymes was evaluated in male Sprague-Dawley rats. Soybeans contain biologically active compounds that are known inducers of phase II enzyme activity. Rats were fed soy flour (SF) or soy protein isolate (SPI) to provide 75% of total protein as soy. Rats were given free access to food for one- and two-week periods before enzyme activity was compared with that of casein control groups (AIN-93G). Hepatic glutathione S-transferase (GST) activity was significantly greater in rats fed SF for one and two weeks and in rats fed SPI for two weeks than in controls. Quinone reductase activity was significantly greater (12- to 14-fold) in the colon of rats fed SF and SPI for two weeks and in serum (1.8- to 2-fold) in the SF group at one and two weeks. Liver, kidney, and small intestine uridine 5'-diphosphate-glucuronosyl transferase activity was significantly increased in the SPI and SF groups at two weeks. A time dependence in induction of phase II enzymes was observed in several tissues. There was no significant difference in total liver glutathione in either diet group compared with controls. The data indicate that dietary soy enhances phase II enzyme activity, especially quinone reductase and uridine 5'-diphosphate-glucuronosyl transferase, which could lead to protection from potentially harmful xenobiotics.


Subject(s)
Enzyme Induction/drug effects , Intestines/enzymology , Kidney/enzymology , Liver/enzymology , Soybean Proteins/pharmacology , Animals , Caseins/pharmacology , Colon/enzymology , Glucuronosyltransferase/biosynthesis , Glutathione Transferase/biosynthesis , Intestine, Small/enzymology , Kinetics , Male , NAD(P)H Dehydrogenase (Quinone)/biosynthesis , Rats , Rats, Sprague-Dawley , Soybean Proteins/administration & dosage
SELECTION OF CITATIONS
SEARCH DETAIL
...